Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis

Surgery Today

Volumn 43, Issue 11, 2013, Pages 1290-1297

  Tanaka, Shogo ^a   Iimuro, Yuji ^a   Hirano, Tadamichi ^a   Hai, Seikan ^a   Suzumura, Kazuhiro ^a   Nakamura, Ikuo ^a   Kondo, Yuichi ^a   Fujimoto, Jiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Body mass index; Hyperlipidemia; Non B non C hepatitis

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE LEAKAGE; BODY WEIGHT; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; INTRACTABLE ASCITES; INTRACTABLE PLEURAL EFFUSION; INTRAOPERATIVE PERIOD; JAPAN; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; OPERATION DURATION; OPERATIVE BLOOD LOSS; POSTOPERATIVE COMPLICATION; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK FACTOR; SAFETY; SURGICAL INFECTION; SURGICAL MORTALITY; TREATMENT RESPONSE;

AGED; BODY MASS INDEX; CARCINOMA, HEPATOCELLULAR; COMORBIDITY; FEMALE; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OBESITY; POSTOPERATIVE COMPLICATIONS; SAFETY;

EID: 84886085315     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-013-0706-2     Document Type: Article

References (52)

1. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-63.
2. McCurry J. Japan battles with obesity. Lancet. 2007;369:451-2.
3. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-200.
4. Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health. 2008;8:200.
5. Lissau I, Overpeck MD, Ruan WJ, Due P, Holstein BE, Hediger ML. Body mass index and overweight in adolescents in 13 European countries, Israel, and the United States. Arch Pediatr Adolesc Med. 2004;158:27-33.
6. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894: i-xii, 1-253.
7. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J. 2002;66:987-92.
8. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664-9.
9. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221-31.
10. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology. 2004;127:S97-103.
11. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51:1972-8.
12. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38-46.
13. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138:1198-206 discussion 206.
14. Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res. 2009;39:107-16.
15. Balzan S, Nagarajan G, Farges O, Galleano CZ, Dokmak S, Paugam C, et al. Safety of liver resections in obese and overweight patients. World J Surg. 2010;34:2960-8.
16. Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet. 2003;361:2032-5.
17. Mathur AK, Ghaferi AA, Osborne NH, Pawlik TM, Campbell DA, Englesbe MJ, et al. Body mass index and adverse perioperative outcomes following hepatic resection. J Gastrointest Surg. 2010;14:1285-91.
18. Ito T, Kiuchi T, Egawa H, Kaihara S, Oike F, Ogura Y, et al. Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases. Transplantation. 2003;76:158-63.
19. Utsunomiya T, Okamoto M, Kameyama T, Matsuyama A, Yamamoto M, Fujiwara M, et al. Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma. World J Gastroenterol. 2008;14:1553-8.
20. Cucchetti A, Cescon M, Ercolani G, Di Gioia P, Peri E, Pinna AD. Safety of hepatic resection in overweight and obese patients with cirrhosis. Br J Surg. 2011;98:1147-54.
21. Ichikawa T, Uenishi T, Takemura S, Oba K, Ogawa M, Kodai S, et al. A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2009;16:42-8.
22. Kubo S, Tsukamoto T, Hirohashi K, Tanaka H, Shuto T, Takemura S, et al. Correlation between preoperative serum concentration of type IV collagen 7 s domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg. 2004;239:186-93.
23. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298-304.
24. Iimuro Y, Kashiwagi T, Yamanaka J, Hirano T, Saito S, Sugimoto T, et al. Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci. 2010;17:673-81.
25. Yasui K, Hashimoto E, Tokushige K, Koike K, Shima T, Kanbara Y, et al. Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma. Hepatol Res. 2012;42:767-73.
26. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413-9.
27. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21.
28. Brunt EM. Non-alcoholic fatty liver disease. In: Burt AD, Portmann BC, Ferrell LD, editors. MacSween's pathology of the liver. 5th ed. London: Churchill Livingstone; 1992. p. 367-97.
29. Couinaud C. Lobes et segments hepatiques. Notes sur larchitecture anatomique du foie. Presse Med. 1954;62:709-12.
30. Belghiti J, Clavien PA, Gadzijev E, Garden JO, Lau WY, Makuuchi M, et al. The Brisbane 2000 terminology of liver anatomy and resection. HPB. 2000;2:333-9.
31. Yamamoto M, Katagiri S, Ariizumi S, Kotera Y, Takahashi Y. Glissonean pedicle transection method for liver surgery (with video). J Hepatobiliary Pancreat Sci. 2012;19:3-8.
32. Pringle JH. V. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48:541-9.
33. Makuuchi M, Mori T, Gunven P, Yamazaki S, Hasegawa H. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet. 1987;164:155-8.
34. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431-5.
35. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513-20.
36. Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011;149:680-8.
37. Tanaka S, Kubo S, Tsukamoto T, Hirohashi K, Tanaka H, Shuto T, et al. Risk factors for intractable pleural effusion after liver resection. Osaka City Med J. 2004;50:9-18.
38. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713-24.
39. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824-8 discussion 8-9.
40. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13.
41. Wei AC, Tung-Ping Poon R, Fan ST, Wong J. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg. 2003;90:33-41.
42. Suzuki K, Endo R, Kohgo Y, Ohtake T, Ueno Y, Kato A, et al. Guidelines on nutritional management in Japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma. Hepatol Res. 2012;42:621-6.
43. Ortiz V, Berenguer M, Rayon JM, Carrasco D, Berenguer J. Contribution of obesity to hepatitis C-related fibrosis progression. Am J Gastroenterol. 2002;97:2408-14.
44. Ratziu V, Giral P, Munteanu M, Messous D, Mercadier A, Bernard M, et al. Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia. Aliment Pharmacol Ther. 2007;25:207-18.
45. Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, Blumenthal RS. Evidence-based use of statins for primary prevention of cardiovascular disease. Am J Med. 2012;125:440-6.
46. Vrazic H, Lucijanic T, Sikic J, Spoljaric IR, Polic S, Ljubicic D, et al. The prevalence of diabetes mellitus and abnormal lipid status among Croatian hospitalized coronary heart disease patients. Coll Antropol. 2012;36(Suppl 1):223-8.
47. Gedaly R, McHugh PP, Johnston TD, Jeon H, Ranjan D, Davenport DL. Obesity, diabetes, and smoking are important determinants of resource utilization in liver resection: a multicenter analysis of 1029 patients. Ann Surg. 2009;249:414-9.
48. Saunders JK, Rosman AS, Neihaus D, Gouge TH, Melis M. Safety of hepatic resections in obese veterans. Arch Surg. 2012;147:331-7.
49. Jones RM, Moulton CE, Hardy KJ. Central venous pressure and its effect on blood loss during liver resection. Br J Surg. 1998;85:1058-60.
50. Kliewer MA, Hertzberg BS, Heneghan JP, Suhocki PV, Sheafor DH, Gannon PA Jr, et al. Transjugular intrahepatic portosystemic shunts (TIPS): effects of respiratory state and patient position on the measurement of Doppler velocities. AJR Am J Roentgenol. 2000;175:149-52.
51. Yoshimura Y, Kubo S, Hirohashi K, Ogawa M, Morimoto K, Shirata K, et al. Plastic iodophor drape during liver surgery operative use of the iodophor-impregnated adhesive drape to prevent wound infection during high risk surgery. World J Surg. 2003;27:685-8.
52. Wei YF, Wu HD, Chang CY, Huang CK, Tai CM, Hung CM, et al. The impact of various anthropometric measurements of obesity on pulmonary function in candidates for surgery. Obes Surg. 2010;20:589-94.